Post-approval studies (Phase 4)Study completedNCT01162421
What this trial is testing
A Canadian Study to Evaluate Early Use of Adalimumab After Methotrexate Failure in Early Rheumatoid Arthritis
Who this might be right for
Rheumatoid Arthritis
AbbVie (prior sponsor, Abbott) 77